FindTrial
Sign In

Improving Health and Quality of Life in People with COPD: The Role of Pharmacist-Led Education and Guideline-Based Care

Impact of pharmacist-led guideline based patient care on clinical and humanistic outcomes in chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095278
Enrollment
178
Registered
2025-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J40-J47- Chronic lower respiratory diseases

Interventions

Intervention1: Interventional study- Randomized control study: The study consists of COPD patients. Each patient is required to be monitored 4 times i.e. baseline, 4th, 8th and 12th month after enroll

Sponsors

Nitte University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients either gender who are diagnosed with COPD and willing to provide the informed consent

Exclusion criteria

Exclusion criteria: a) Patients with other respiratory tract infections b) Patients with cancer, end-stage renal disease, heart failure c) Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Impact of pharmaceutical care in improving clinical and humanistic outcomes in COPD patientsTimepoint: 0 4 8 12 months—

Secondary

MeasureTime frame
Secondary outcomes: Measurement of medication adherence, p0atient satisfaction, cost of illness and severity assessment.Timepoint: 0 4 8 12 months—

Countries

India

Contacts

Public ContactDr Milagrin Xavier

NGSM Institute of Pharmaceutical Sciences

junojoel@nitte.edu.in9480470727

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026